Noci Darlene sold $138K of NUVL
Noci Darlene (Chief Development Officer) sold 1,300 shares of Nuvalent, Inc. (NUVL) at $106.26 ($0.14M total) on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly under a pre-arranged Rule 10b5-1 plan, it is generally treated as routine rather than new fundamental information.
Market read
Traders may note the disclosure for sentiment/positioning, but it does not introduce a new catalyst for Nuvalent.
What to watch
The disclosure does not reveal the insider’s rationale; the sale size and whether it’s part of a broader cadence matter more than this single print.
Background
The article is an SEC EDGAR Form 4 insider transaction for Nuvalent, Inc. (NUVL).
Ticker impact
Nuvalent CDO Noci Darlene sold 1,300 shares in an open-market transaction disclosed via SEC Form 4 on May 28.
Likely limited immediate price impact; any effect would be sentiment-driven and short-lived.
The filing is an ownership-change disclosure (Form 4) with a stated pre-arranged 10b5-1 plan, reducing the likelihood of information-based trading.
Market effects
Minimal; this is company-specific insider activity without new clinical/financial catalysts.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider sales can coincide with periods of reduced confidence or liquidity needs—watch for follow-on selling patterns.
Key entities
- issuerNuvalent, Inc.
Company whose insider transaction is disclosed.
- insiderNoci Darlene
Chief Development Officer who sold shares.
